| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 240.327 | 85 |
| GSM780708 | Untreated after 4 days (C2_1) | 185.646 | 83 |
| GSM780709 | Untreated after 4 days (C3_1) | 174.971 | 82 |
| GSM780719 | Untreated after 4 days (C1_2) | 236.744 | 85 |
| GSM780720 | Untreated after 4 days (C2_2) | 218.824 | 84 |
| GSM780721 | Untreated after 4 days (C3_2) | 182.16 | 83 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 203.196 | 84 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 230.195 | 85 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 243.399 | 85 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 198.481 | 83 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 212.913 | 84 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 253.054 | 86 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 229.839 | 85 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 215.088 | 84 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 206.363 | 84 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 212.064 | 84 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 219.021 | 84 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 228.628 | 85 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 230.882 | 85 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 274.964 | 87 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 253.003 | 86 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 228.796 | 85 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 254.448 | 86 |